Drugs / Juvéderm® Voluma™ XC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05386030 | Aug 2022 → Oct 2023 | midface dysplasia | Croma-Pharma GmbH | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Juvéderm Voluma XC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05386030 ↗ |